MMedication Read More Pharmaceutical Shortage Leads to Nationwide Black MarketAugust 19, 2026 Amid ongoing pharmaceutical shortages in Iran, the illicit market for hard-to-find medications continues to flourish along Tehran’s Nasser…
MMedication Read More Amylyx endocrine drug succeeds in pivotal studyAugust 19, 2026 This story is republished from STAT, the health and medicine news site that’s a partner to the Globe.…
MMedication Read More Zepbound Helped Me Get Healthier, I Need to Stop Apologizing for ItAugust 19, 2026 “You look great! Did you lose weight?” a friend I hadn’t seen in a few weeks asked, barely…
MMedication Read More Some people are taking Cialis for more than sex : NPRAugust 19, 2026 Transcript SACHA PFEIFFER, HOST: The drug tadalafil, known by its brand name Cialis, is taken by millions of…
MMedication Read More Fake medicines in ICUs? Relabelled drugs supplied to Karnataka hospitals, pharmacies, says minister | Bengaluru NewsAugust 19, 2026 Samples of the seized medicines have been sent for laboratory testing to verify their chemical composition, sterility and…
MMedication Read More Single dose malaria drug could simplify treatment worldwide in medical breakthroughAugust 19, 2026 Your support helps us to tell the story From reproductive rights to climate change to Big Tech, The…
MMedication Read More UAE approves 10 medicines in 1 year: How these rare drugs help treat patientsAugust 19, 2026 Over the past year, the UAE has approved many new medicines and new uses for existing treatments, covering…
MMedication Read More Autoinjectable PCSK9 Inhibitor; Caution on CoQ10; Ohio Doc’s Rape ChargesAugust 19, 2026 The FDA approved the autoinjector version of lerodalcibep (Lerochol), a PCSK9 inhibitor for LDL cholesterol lowering, LIB Therapeutics…
MMedication Read More FDA-Approved Drug Shows Promise for Reversing Osteoarthritis DamageAugust 19, 2026 An epilepsy drug may have an unexpected second use in osteoarthritis, where researchers found it could help shift…
MMedication Read More EyePoint’s Duravyu falls short to Eylea in Phase III trialAugust 19, 2026 EyePoint’s stock dropped 67% after its potential Eylea (aflibercept) competitor Duravyu fell short in a Phase III trial…
MMedication Read More US man posed as doctor in scheme to profit from Ozempic, prosecutors say | IllinoisAugust 18, 2026 An Illinois man who allegedly impersonated doctors – and evidently referred to himself online as “$hotboy1” – is…
MMedication Read More Enveda Reports Positive Phase 1 Results for ENV-308, the First Pill Designed From the Chemistry of ExerciseAugust 18, 2026 BOULDER, Colo.–(BUSINESS WIRE)–1 in 8 US adults are reported to use GLP-1 medications, but the majority of people…